NorthWest Biotherapeutics Inc (NWBO)

[ae kusterer]

Dan88:I apologize for being a week late in reacting to this post(419819) of yours . So, what I take away from what you and Flipper are saying(as guided by DI) about the timing of the scientific publication on the dc vax l phase 3 trial is: add 1-2 months onto 11/5/21 , which is the 13 month known average of scientific publications , post datalock. Am I on target, or not, with your thinking? A.E.Kusterer( reply by email if you want , to [e-mail] ) (give me your cell number, and I can call)



Dan88 Saturday, 11/20/21 12:23:49 PM
Re: Flexroy post# 419818
Post #
419819
of 422174
here https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166839170

[[ Hutaaga Friday, 11/19/21 11:15:42 AM
Re: None 0
Post # of 419818

Thought I would share this with you.

Talked to Dave and spent good 25 mins this morning.

The summary is, it is now really is depend on the journal publication. If they release something early, it may jeoperdize the publication.

The holding is mostly due to these peer reviews were having hard times getting information because lots of the sources were shutdown due to covid.
Other than that, everything is lining up well.

So it is what it is.

He said they are working hard to stay on top of everything and trying to get it right, but can only do so much on their part.

He did mention that the average time from DL to publication is 13 months, so add a few months delays to that. ]]

Note: Flipper later talked to DI as well clarifying DI never said it would take several more months.